<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bronchoscopic cryotechniques in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bronchoscopic cryotechniques in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bronchoscopic cryotechniques in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Henri G Colt, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David J Feller-Kopman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Several bronchoscopic cryosurgical techniques are available that employ extremely low temperatures to freeze tissue for destruction (cryoablation), adhesion (cryoadhesion), or biopsy (cryobiopsy) [<a href="#rid1">1-3</a>]. The most common of these is cryoablation, a procedure that is mostly used to manage inoperable airway obstruction. The equipment, principles, techniques, indications, contraindications, and complications of these modalities are reviewed here. Other bronchoscopic techniques used to manage airway obstruction are described separately. (See  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"</a> and  <a class="medical medical_review" href="/d/html/4396.html" rel="external">"Endobronchial electrocautery"</a> and  <a class="medical medical_review" href="/d/html/4382.html" rel="external">"Endobronchial photodynamic therapy in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4403.html" rel="external">"Airway stents"</a> and  <a class="medical medical_review" href="/d/html/4402.html" rel="external">"Flexible bronchoscopy balloon dilation for nonmalignant airway strictures (bronchoplasty)"</a> and  <a class="medical medical_review" href="/d/html/4408.html" rel="external">"Endobronchial brachytherapy"</a>.)</p><p class="headingAnchor" id="H4056351"><span class="h1">EQUIPMENT</span><span class="headingEndMark"> — </span>Bronchoscopic cryotechniques require a cryosurgery device (ie, cryoprobe or cryoforceps), bronchoscope, and cooling agent (ie, cryogen). Only experts skilled in the use of this equipment should perform cryosurgery  (<a class="graphic graphic_picture graphicRef104187" href="/d/graphic/104187.html" rel="external">picture 1</a>). The procedure can be performed in the operating room or specialized procedure suites.</p><p class="headingAnchor" id="H4056382"><span class="h2">Cryosurgery device</span><span class="headingEndMark"> — </span>Cryosurgery devices consist of a cryoprobe (ablative or adhesive procedures) or a cryoforceps (biopsy procedures), a transfer line, and a console. The cryoprobe/forceps is used to freeze the target tissue. The transfer line connects the cryoprobe/forceps to both the cooling agent storage container (eg, gas cylinder) and the console. The console controls the flow of cooling agent through the transfer line. (See <a class="local">'Cryoablation'</a> below and <a class="local">'Cryoadhesion'</a> below and <a class="local">'Cryobiopsy'</a> below.)</p><p>Cryoprobes may be rigid, semirigid, or flexible. Rigid cryoprobes have a system of reheating that induces a nearly immediate thaw phase, whereas thawing is a passive process with flexible cryoprobes, such that the freeze-thaw cycle is longer with the latter. Cryoforceps are typically flexible.</p><p class="headingAnchor" id="H4056388"><span class="h2">Bronchoscope</span><span class="headingEndMark"> — </span>Rigid and semirigid cryoprobes can be used through a rigid bronchoscope only, whereas flexible cryoprobes and forceps can be used through either a flexible or a rigid bronchoscope. (See  <a class="medical medical_review" href="/d/html/4398.html" rel="external">"Flexible bronchoscopy in adults: Overview"</a> and  <a class="medical medical_review" href="/d/html/4390.html" rel="external">"Rigid bronchoscopy: Instrumentation"</a>.)</p><p class="headingAnchor" id="H4056416"><span class="h2">Cooling agents (cryogen)</span><span class="headingEndMark"> — </span>The cooling agents that are used most often are <a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">nitrous oxide</a> and liquid nitrogen:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">Nitrous oxide</a> – Nitrous oxide (N<sub>2</sub>O) is the most commonly used cryogen [<a href="#rid4">4</a>]. It is stored in the liquid state at room temperature in high-pressure bottles. The vapor haze of N<sub>2</sub>O occurs at the metal tip of the cryoprobe, where it expands as it goes from high pressure to atmospheric pressure. This expansion lowers the temperature of the fluid (via the Joule-Thomson effect) and produces droplets of liquid. The result is an equilibrium temperature of -89°C in the distal two centimeters of the cryoprobe.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>While carbon dioxide (CO<sub>2</sub>) has been an attractive cryogen for treating skin lesions, it was initially felt to be unsuitable for bronchoscopic cryosurgery because it produces snow when it expands at atmospheric pressure. These solid particles would obstruct the instrument channel in the bronchoscope. Technological advances, however, enable carbon dioxide systems with a cooling power similar to or equal to that of cooling temperatures provided using N<sub>2</sub>O, and given abuse/black-market value of N<sub>2</sub>O, CO<sub>2</sub> has become the cryogen of choice in many institutions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Liquid nitrogen</strong> – Liquid nitrogen (LN<sub>2</sub>) is stored near its saturation temperature of -196°C in vacuum-insulated containers. It evaporates as it passes through the transfer line at room temperature, leaving gaseous nitrogen to slowly cool the metal tip of the cryoprobe (the temperature of -196°C is reached in approximately one minute). Once the temperature in the transfer line becomes sufficiently low, evaporation is prevented and droplets of LN<sub>2</sub> bombard the inner wall of the metal tip of the cryoprobe, cooling the cryoprobe at a more rapid rate [<a href="#rid5">5</a>].</p><p></p><p>Choosing among these agents is often dependent upon availability, clinician experience, and institutional biases. While research data are not available, most clinicians seem to prefer using N<sub>2</sub>O because larger freeze zones from LN<sub>2</sub> exposes tissues to greater shear damage, and therefore possible perforation.</p><p class="headingAnchor" id="H4055707"><span class="h1">CRYOABLATION</span><span class="headingEndMark"> — </span>Cryoablation (also known as cryotherapy) uses exceptionally low temperatures to destroy tissue with repeated cycles of rapid freezing and slow thawing of target tissue  (<a class="graphic graphic_figure graphicRef112826" href="/d/graphic/112826.html" rel="external">figure 1</a>). Cryoadhesion and cryobiopsy are defined below. Among the techniques, cryoadhesion for foreign body removal is the technique that is most commonly used. (See <a class="local">'Cryoadhesion'</a> below and <a class="local">'Cryobiopsy'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h2">Basic principles and mechanisms of action</span><span class="headingEndMark"> — </span>Freezing tissue to -20°C or below at a rapid rate (-100°C per minute) results in the development of intracellular ice crystals, which induce more than 90 percent cell death [<a href="#rid6">6-13</a>]. Tissue is thawed slowly to allow intracellular crystals to increase in size before they melt, resulting in further tissue destruction.</p><p>Intracellular ice crystals cause cell death by the following mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>Damaging mitochondria or other micro-organelles</p><p class="bulletIndent1"><span class="glyph">●</span>Cellular dehydration</p><p class="bulletIndent1"><span class="glyph">●</span>Increased concentration of intracellular electrolytes</p><p class="bulletIndent1"><span class="glyph">●</span>Denaturation of membrane lipoproteins resulting in cellular swelling and increased permeability</p><p></p><p>Cryoablation also induces ischemic necrosis, independent of the direct cellular damaging effect. Vascular changes include initial vasoconstriction of arterioles and venules, altered vascular endothelium, increased permeability of vascular walls, increased blood viscosity, lower intracapillary hydrostatic pressure, decreased blood flow, and formation of platelet plugs. Ischemic necrosis from thrombosis of the target tissue microcirculation is thought to be responsible for the minimal bleeding associated with this modality. The end result is a clear line of demarcation between previously frozen tissue and unfrozen tissue.</p><p>Certain tissues are highly sensitive to freezing-induced destruction (ie, cryosensitive), while others are less sensitive (ie, cryoresistant). Examples of cryosensitive tissues include the skin, mucous membrane, granulation tissue, and tumor cells. Examples of cryoresistant tissues include fat, cartilage, fibrous, and connective tissue (ie, normal airway).</p><p>The depth of tissue penetration is approximately 3 mm, however this depends on the freeze time and cryosensitivity of the tissue [<a href="#rid14">14</a>]. This feature together with the resistance of cartilage to cryotherapy lowers the risk of airway perforation when compared with other bronchoscopic ablative techniques such as laser or electrocautery. (See  <a class="medical medical_review" href="/d/html/4392.html" rel="external">"Bronchoscopic laser in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4396.html" rel="external">"Endobronchial electrocautery"</a>.)</p><p>Importantly, the destructive effects of cryoablation are not immediate, but rather delayed such that it takes a number of days to weeks for the full effect of tissue necrosis to occur with continued tissue sloughing that often necessitates bronchoscopic removal of necrosed tissue during follow-up. Although attempts were made to overcome this delayed effect by using a larger probe to debulk tumor during the procedure, this form of cryotherapy ("cryorecanalization") was complicated by significant hemorrhage (up to 10 percent requiring argon plasma coagulation) and remains investigational [<a href="#rid15">15</a>]. (See <a class="local">'Complications'</a> below and <a class="local">'Follow-up'</a> below.)</p><p>Large amounts of endobronchial tumors may be removed by a combination of cryoadhesion and cryoablation technique. This technique can especially be helpful for endobronchial tumor debulking in patients who cannot tolerate lower FiO<sub>2</sub> as all thermal debulking modalities (neodymium-doped yttrium aluminum garnet [Nd-YAG] laser, argon plasma coagulation [APC], electrocautery) require a fraction of inspired oxygen (FiO<sub>2</sub>) &lt;40 percent to prevent airway fire.</p><p class="headingAnchor" id="H4051796"><span class="h2">Indications and efficacy</span><span class="headingEndMark"> — </span>Bronchoscopic cryoablation is primarily a palliative or adjunctive therapy used for the relief of inoperable symptomatic central airway obstruction (CAO) most commonly due to malignant conditions [<a href="#rid1">1-3,16</a>]. Less commonly, it is used to treat CAO due to nonmalignant conditions, and rarely, it is used to treat hemoptysis or inoperable microinvasive lung carcinoma. Since its efficacy is dependent upon direct contact, ideal lesions are intraluminal; it is not suitable for lesions causing external compression. Since the effect of bronchoscopic cryoablation is delayed (ie, days to weeks), other modalities are generally favored for those with life-threatening obstruction who need immediate relief. Although most cases of airway obstruction are located centrally (ie, trachea and mainstem bronchi), lesions down to the second or third order of bronchi can be successfully treated with cryoablation provided they are accessible to the cryoprobe and to subsequent cleanup bronchoscopy.</p><p>The approach to and choice of modality used to treat patients with CAO as well as a comparison between the locally ablative bronchoscopic techniques are discussed separately  (<a class="graphic graphic_table graphicRef72854" href="/d/graphic/72854.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef64246" href="/d/graphic/64246.html" rel="external">table 2</a>). Similar to other interventional techniques, cryotherapy can be used alone or in combination with stent insertion or airway dilation. (See  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"</a>.)</p><p class="headingAnchor" id="H4051911"><span class="h3">Central airway obstruction</span><span class="headingEndMark"> — </span>The etiologies and efficacy to support cryoablation as a treatment for inoperable CAO due to malignant or nonmalignant obstruction are discussed in this section  (<a class="graphic graphic_table graphicRef55320" href="/d/graphic/55320.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H4051934"><span class="h4">Malignant lesions</span><span class="headingEndMark"> — </span>Airway malignancy is a common indication for bronchoscopic cryotherapy. Ideal patients are those who have symptomatic, intraluminal malignancies (eg, cough, dyspnea, hemoptysis, atelectasis) that are not associated with life-threatening obstruction. Numerous studies have found that cryotherapy is beneficial for airway obstruction due to malignant lesions  (<a class="graphic graphic_table graphicRef55320" href="/d/graphic/55320.html" rel="external">table 3</a>), whether performed via rigid or flexible bronchoscopy with successful reestablishment of airway patency in up to 90 percent of patients [<a href="#rid5">5,15,17-21</a>]. Similar to other interventional techniques, cryotherapy can be used alone or in combination with stent insertion or airway dilation to maximize patency. (See  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"</a>.)</p><p>Data to support cryoablative therapy via rigid or flexible bronchoscopy are derived from observational case series:</p><p class="bulletIndent1"><span class="glyph">●</span>Cryoablation via rigid bronchoscopy – An uncontrolled case series of 33 consecutive patients who underwent 81 cryotherapy sessions using a rigid bronchoscope found that airway obstruction was relieved in 77 percent of patients [<a href="#rid17">17</a>]. Lung function and symptoms improved in approximately 60 percent of patients. Other studies (over 800 patients in total) have reported similar results with subjective improvement in 65 to 78 percent, many of whom had more than one session of cryoablation [<a href="#rid18">18,19,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cryoablation via flexible bronchoscopy – A review of 225 patients found that cryotherapy delivered via a flexible bronchoscope relieved the airway obstruction in more than 90 percent of patients, although 20 percent had an additional interventional procedure (eg, argon plasma coagulation, endobronchial stent) [<a href="#rid23">23</a>]. A smaller review with 22 patients similarly found that airway obstruction was relieved in approximately 90 percent of patients, after which lung function improved in 58 percent [<a href="#rid20">20</a>].</p><p></p><p>Bronchoscopic cryoablation has been used in combination with chemotherapy and radiation with limited data to suggest that it may increase the chemo- or radiosensitivity of the tumor [<a href="#rid13">13,21,22,24-26</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Cryoablation plus chemotherapy – Increased accumulation of chemotherapeutic agent within the tumor following cryotherapy has been demonstrated in small observational series [<a href="#rid24">24,25</a>]. However, the relationship between cryosurgery-induced accumulation of a chemotherapeutic agent and decreased tumor growth was reported in animal studies only [<a href="#rid27">27-29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cryoablation plus radiation – In a review of 38 patients treated with cryotherapy followed by radiation, a higher proportion of patients achieved local control of the obstructing tumor, when compared with historical controls (65 versus 35 percent) [<a href="#rid26">26</a>]. It has been hypothesized that the possible increased sensitivity to radiation therapy may be due to cryotherapy-induced neovascularization [<a href="#rid30">30</a>].</p><p></p><p>Most cases of CAO treated with bronchoscopic cryotherapy have non-small cell lung cancer (NSCLC). However, use of this modality in patients with inoperable CAO due to other malignancies including airway carcinoid and airway metastases of extrapulmonary origin has also been reported [<a href="#rid22">22,31-33</a>]. As an example, in an uncontrolled case series, 18 patients with typical endobronchial carcinoid that was inoperable underwent bronchoscopic cryoablation [<a href="#rid31">31</a>]. Only one patient (6 percent) had a recurrence, which occurred seven years after the intervention. Similarly, in an observational series of 35 patients with mostly colorectal or renal airway metastases, endoluminal patency was increased by ≥50 percent in most patients following cryotherapy and symptoms improved in 85 percent of cases; the median survival was 34 weeks. (See  <a class="medical medical_review" href="/d/html/85914.html" rel="external">"Lung neuroendocrine (carcinoid) tumors: Treatment and prognosis", section on 'Surgical resection'</a>.)</p><p class="headingAnchor" id="H4052553"><span class="h4">Nonmalignant lesions</span><span class="headingEndMark"> — </span>There is less evidence regarding the successful use of bronchoscopic cryotherapy for treating CAO due to inoperable nonmalignant lesions [<a href="#rid21">21,34-44</a>]. Similar to patients with malignant CAO, nonmalignant lesions suitable for cryoablation are intraluminal lesions of the trachea and mainstem bronchus that are not extensive and not associated with life-threatening obstruction. (See <a class="local">'Malignant lesions'</a> above and  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"</a>.)</p><p>Examples of nonmalignant conditions that have been successfully treated with bronchoscopic cryotherapy include the following [<a href="#rid5">5,21,35-42</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Granulation tissue due to bronchial anastomoses following lobectomy or lung transplantation</p><p class="bulletIndent1"><span class="glyph">●</span>Endobronchial lipoma, hamartoma, and hemangioma</p><p class="bulletIndent1"><span class="glyph">●</span>Blood clots</p><p class="bulletIndent1"><span class="glyph">●</span>Mycetoma</p><p class="bulletIndent1"><span class="glyph">●</span>Endobronchial tuberculosis</p><p class="bulletIndent1"><span class="glyph">●</span>Removal of mucus plugs</p><p class="bulletIndent1"><span class="glyph">●</span>Removal of foreign bodies</p><p></p><p>However, compared with malignant tissue which in general is more cryosensitive, some nonmalignant endobronchial lesions may be cryoresistant, such as those associated with fibrotic tissue. As an example, it is usually not used to treat fibrotic tracheal strictures as precise resection is less feasible with this technique and large circumferential zones of collateral tissue damage can occur. The latter can result in restenosis and sometimes, worsen the tracheal stricture (eg, lengthen it) which, in turn, can make definitive surgical correction more problematic. In such cases, laser, electrocautery, or argon plasma coagulation may be more appropriate. (See  <a class="medical medical_review" href="/d/html/4396.html" rel="external">"Endobronchial electrocautery"</a> and  <a class="medical medical_review" href="/d/html/4392.html" rel="external">"Bronchoscopic laser in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a>.)</p><p class="headingAnchor" id="H4053103"><span class="h3">Hemoptysis</span><span class="headingEndMark"> — </span>Bronchoscopic cryotherapy can achieve hemostasis in patients with significant hemoptysis due to visible airway lesions [<a href="#rid17">17</a>]. However, among the bronchoscopic modalities, it is generally not as effective in achieving rapid hemostasis as argon plasma coagulation (APC) or laser. In addition, delayed hemorrhage is a known complication of cryoablation that may require APC for treatment. (See  <a class="medical medical_review" href="/d/html/4392.html" rel="external">"Bronchoscopic laser in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a>.)</p><p class="headingAnchor" id="H4053123"><span class="h3">Inoperable microinvasive carcinoma</span><span class="headingEndMark"> — </span>Case reports suggest that locally ablative bronchoscopic therapies have the potential to be effective as a treatment for microinvasive radiographically occult lung cancer that is inoperable [<a href="#rid45">45,46</a>]. However, in the largest case series that demonstrated benefit, electrocautery was the most common modality used and cryotherapy was not studied [<a href="#rid45">45</a>].</p><p>Percutaneous cryoablation of parenchymal tumors under computed tomographic guidance has been described but remains investigational [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H4053200"><span class="h2">Contraindications</span></p><p class="headingAnchor" id="H4053206"><span class="h3">Extrinsic airway compression</span><span class="headingEndMark"> — </span>Bronchoscopic cryoablation has no role when the obstruction is due to external compression since its efficacy requires direct contact with the cryoprobe. However, obstructive intraluminal components of extrinsic lesions may be subjected to cryoablation, if necessary.</p><p class="headingAnchor" id="H4053212"><span class="h3">Contraindications to bronchoscopy</span><span class="headingEndMark"> — </span>Bronchoscopic cryoablation involves either flexible or rigid bronchoscopy, which typically requires procedural sedation or general anesthesia. Thus, contraindications to bronchoscopy, procedural sedation and/or general anesthesia are also considered contraindications to this procedure. These are reviewed separately. (See  <a class="medical medical_review" href="/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications", section on 'General considerations and precautions'</a> and  <a class="medical medical_review" href="/d/html/4400.html" rel="external">"Flexible bronchoscopy in adults: Indications and contraindications", section on 'Contraindications'</a> and  <a class="medical medical_review" href="/d/html/399.html" rel="external">"Overview of anesthesia", section on 'Risk assessment'</a>.)</p><p class="headingAnchor" id="H4053252"><span class="h3">Immediate relief of airway symptoms</span><span class="headingEndMark"> — </span>As the full effects of bronchoscopic cryoablation take days to weeks to restore airway patency, other modalities may be preferred for patients who require immediate relief from airway obstruction or massive hemoptysis. However, it can be used to rapidly open an airway as long as the operator understands that further tissue necrosis and edema may occur over the subsequent 48 to 72 hours. Similarly, it cannot be used in patients with significant airway obstruction who are at risk of airway compromise due to airway edema, which can complicate the procedure. In these situations, a procedure that resects the tissue and immediately restores airway patency or controls bleeding (eg, electrocautery, laser, argon plasma coagulation, stenting) are more appropriate. (See  <a class="medical medical_review" href="/d/html/4396.html" rel="external">"Endobronchial electrocautery"</a> and  <a class="medical medical_review" href="/d/html/4392.html" rel="external">"Bronchoscopic laser in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a>.)</p><p class="headingAnchor" id="H4053292"><span class="h3">Other</span><span class="headingEndMark"> — </span>Cryoablation should be avoided if mucus plugging from tissue sloughing, which is common following the procedure, is likely to worsen impending respiratory failure.</p><p class="headingAnchor" id="H5429704"><span class="h2">Procedure and technique</span><span class="headingEndMark"> — </span>Choosing whether a flexible or rigid bronchoscope will be used typically depends upon the operator’s skill set, available equipment, and general medical and cardiopulmonary status of the patient. In general, rigid bronchoscopy is used in patients with unstable airways or with underlying cardiopulmonary disease who may not tolerate procedural sedation for flexible bronchoscopy. (See  <a class="medical medical_review" href="/d/html/4391.html" rel="external">"Rigid bronchoscopy: Intubation techniques"</a> and <a class="local">'Bronchoscope'</a> above and  <a class="medical medical_review" href="/d/html/4398.html" rel="external">"Flexible bronchoscopy in adults: Overview"</a> and  <a class="medical medical_review" href="/d/html/105799.html" rel="external">"Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Preprocedural preparation'</a> and  <a class="medical medical_review" href="/d/html/105799.html" rel="external">"Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Entering the tracheobronchial tree'</a>.)</p><p>Once the endobronchial lesion has been identified bronchoscopically, the cryoprobe is inserted through the bronchoscope (either a working channel of a flexible bronchoscope or the barrel of a rigid bronchoscope):</p><p class="bulletIndent1"><span class="glyph">●</span>The probe is next advanced until the tip has emerged from the distal port of the bronchoscope and is then placed adjacent to the target tissue:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The probe is passed well beyond the tip of the bronchoscope so that the growing frozen area does not come into contact with the distal extremity of the scope itself. Precise distances cannot be recommended as the angulation and appearances may change depending on the location of the lesion, the position of the bronchoscope, and the type of probe used. If during freezing, the forming ice ball is growing, the scope may need to be slightly retracted to move away from it.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For lesions that directly project into the lumen, the metallic tip of the cryoprobe is either placed onto or pushed into the target tissue. This produces circumferential freezing of maximal volume.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For infiltrating, flat lesions, the cryoprobe is placed so that it has lateral tangential contact with the target tissue.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Three freeze-thaw cycles are then carried out. Some cryoprobes are equipped with a device that measures impedance. When such cryoprobes are used, reheating is begun when a plateau between 250 and 500 kilo-ohms is reached. Subsequent freezing cycles are commenced when the impedance has fallen to 50 kilo-ohms, but before the probe becomes unstuck. If a cryoprobe is used that does not measure impedance, the freezing and reheating times must be estimated. This is done visually, by watching the halo of ice form around the cryoprobe. When the halo stops growing, freezing should be terminated and the tissue allowed to warm up. Generally speaking, a freezing time of approximately one minute is required for the first freeze-thaw cycle when liquid nitrogen is the cooling agent. The freezing time is shorter during subsequent cycles. In contrast, a freezing time of roughly 30 seconds per freeze-thaw cycle is required when <a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">nitrous oxide</a> is the cooling agent. There is no value in prolonging the freezing beyond this time; instead, greater tissue destruction can be achieved by performing more freeze-thaw cycles.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The probe is then moved 5 to 6 mm and another three freeze-thaw cycles are performed. Each freeze zone should overlap the previous freeze zone (similar to a Venn diagram with overlapping circles). The procedure is continued until the entire endobronchial lesion has been treated. The frozen areas are larger with liquid nitrogen than <a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">nitrous oxide</a>; thus, fewer freeze-thaw cycles are necessary and the procedure tends to be shorter when liquid nitrogen is used. (See <a class="local">'Cooling agents (cryogen)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When performing cryoexcision, as with foreign body removal, the frozen tumor (or foreign body) is removed en bloc with the bronchoscope and cryoprobe <strong>during</strong> a freeze cycle. It is important to note that when performing this technique for tumor excision this is the time significant bleeding can occur and it is crucial to get the bronchoscope back in the airway as soon as possible to assess for this complication.</p><p></p><p>The cryoprobe should be removed from the flexible bronchoscope only after it has completely thawed. Any icicle adherent to the probe may damage the working channel of the bronchoscope. This is less likely to occur when using a cryoprobe placed through the barrel of a rigid bronchoscope.</p><p>It is noteworthy that any back-freezing effect (with a snow-like appearance on the outside of the probe or on the probe's tip) can be caused by contact of a cold probe with moist air  (<a class="graphic graphic_picture graphicRef112825" href="/d/graphic/112825.html" rel="external">picture 2</a>). Theoretically, this phenomenon does not correlate with the type of gas being utilized because any cold gas transported from the probe's tip back through the probe may cause a back-freezing effect. To our knowledge, there are no published reports of bronchoscopes damaged from back-freezing. Regardless, most specialists advise keeping the metal tip of the cryoprobe as well as a portion of the plastic hose of the probe fully in view beyond the tip of the flexible bronchoscope during cryo application.</p><p>As an alternative to direct contact cryoablation, a noncontact approach has been reported where liquid nitrogen is sprayed onto the lesion through a specially designed cryocatheter ("spray cryotherapy") [<a href="#rid48">48-50</a>]. It has a potential advantage of treating large areas rapidly and uniformly. Several case series report success treating nonmalignant airway strictures when combining this technique with mechanical dilation or ablative techniques [<a href="#rid49">49,51</a>]. However complications are common and include barotrauma, nitrogen gas embolism, and death. For example, in one study of 80 patients treated with spray cryotherapy, although rates of airway patency and hemostasis were high (&gt;90 percent), 19 percent had complications including hypotension, bradycardia, tachycardia, ST segment changes, desaturation, airway perforation, and death [<a href="#rid49">49</a>]. Consequently, this approach should be considered investigational with patients only treated as part of an investigational study.</p><p class="headingAnchor" id="H11"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Adverse events due to bronchoscopic cryoablation occur in approximately 5 percent of cases or less, with delayed hemorrhage and airway edema being the most common.</p><p>Complications generally relate to bronchoscopy itself but can also be cryotherapy-specific [<a href="#rid14">14,18,20,21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchoscopy or sedation-related</strong> – Many of the complications associated with bronchoscopic cryosurgery are related to bronchoscopy and/or sedation. These complications are discussed separately. (See  <a class="medical medical_review" href="/d/html/4391.html" rel="external">"Rigid bronchoscopy: Intubation techniques", section on 'Complications'</a> and  <a class="medical medical_review" href="/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications", section on 'Anticipating and mitigating Complications'</a> and  <a class="medical medical_review" href="/d/html/4398.html" rel="external">"Flexible bronchoscopy in adults: Overview"</a> and  <a class="medical medical_review" href="/d/html/105799.html" rel="external">"Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Complications'</a> and  <a class="medical medical_review" href="/d/html/399.html" rel="external">"Overview of anesthesia", section on 'Risk assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cryotherapy-related</strong> – Similar to other bronchoscopic ablative procedures, common serious complications include hemorrhage and airway wall ulceration or perforation. Unlike other ablative procedures cryotherapy is not associated with the risk of airway fire.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemorrhage</strong> – Specific to cryoablation, tumor necrosis and the delayed hemostatic effect can result in hemoptysis in up to 4 percent of patients, higher if cryoablative debulking/recanalization techniques are used [<a href="#rid23">23</a>]. Patients with hemorrhage should be treated similar to other patients who present with significant hemoptysis; as an example, case reports describe patients being easily treated with bronchoscopic argon plasma coagulation. (See  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4394.html" rel="external">"Evaluation and management of life-threatening hemoptysis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Airway wall ulceration and perforation</strong> – This complication is less common with cryoablation than with other ablative techniques including laser and electrocautery. Any resulting pneumothorax may require a chest tube or significant airway perforation may need to be repaired. (See  <a class="medical medical_review" href="/d/html/1644.html" rel="external">"Complications of the endotracheal tube following initial placement: Prevention and management in adult intensive care unit patients", section on 'Tracheoesophageal fistula'</a> and  <a class="medical medical_review" href="/d/html/4405.html" rel="external">"Bronchoscopic argon plasma coagulation in the management of airway disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4394.html" rel="external">"Evaluation and management of life-threatening hemoptysis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Airway edema and mucus plugging</strong> – Mild reactive airway edema can occur that is usually not severe because the cartilaginous armature limits swelling. In addition, mucus plugging and atelectasis from cellular debris commonly occurs in the first 48 to 72 hours following the procedure necessitating repeat bronchoscopy for pulmonary toileting. In rare cases, edema and secretions may lead to airway compromise or respiratory insufficiency that sometimes requires intubation and mechanical ventilation. Therapeutic bronchoscopy is typically necessary to clean up debris, should this complication occur.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other</strong> – Other complications including air embolism and fistula formation have not been reported but based upon other ablative procedures are theoretical possibilities. Death is rare.</p><p></p><p class="bulletIndent2">While of uncertain clinical significance, an increase in circulating tumor cells has been reported with endobronchial cryotherapy [<a href="#rid52">52</a>].</p><p></p><p class="headingAnchor" id="H4056687"><span class="h2">Follow-up</span></p><p class="headingAnchor" id="H4056693"><span class="h3">Postoperative care</span><span class="headingEndMark"> — </span>Bronchoscopic cryoablation does not require any particular immediate follow-up care in the absence of complications, other than routine post-bronchoscopy care. Patients usually can return home the same day when performed as an outpatient procedure. However, the expectoration of debris and blood is not uncommon in the days or weeks following cryoablation; atelectasis should be prevented with incentive spirometry and/or chest physical therapy. For this reason, repeat bronchoscopy is generally required. (See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Lung expansion'</a> and <a class="local">'Repeat bronchoscopy'</a> below.)</p><p>Corticosteroids are generally not needed, but they are sometimes administered for 24 hours following cryosurgery on a tracheal or subglottic lesion if the risk of airway compromise is judged to be high. Similarly antibiotics are not administered unless postobstructive pneumonia is evident.</p><p>Similar to any ablative procedure, the efficacy is generally determined by comparing the following factors before and after cryoablation: clinical status (ie, symptoms), radiologic appearance, and respiratory function. The optimal time for this evaluation is unknown but symptoms are generally assessed immediately as well as a few weeks following the procedure. In addition, because cryoablation, unlike some of the other ablative procedures (eg, laser), is invariably followed up with repeat bronchoscopy, the endoscopic appearance after the procedure can also be routinely evaluated. The general follow-up of patients with central airway obstruction is discussed separately. (See  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults", section on 'Follow-up'</a> and  <a class="medical medical_review" href="/d/html/4398.html" rel="external">"Flexible bronchoscopy in adults: Overview"</a> and  <a class="medical medical_review" href="/d/html/105799.html" rel="external">"Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Postprocedure monitoring'</a>.)</p><p class="headingAnchor" id="H4056721"><span class="h3">Repeat bronchoscopy</span><span class="headingEndMark"> — </span>Repeat bronchoscopy (usually flexible bronchoscopy) is generally performed 2 to 10 days after bronchoscopic cryoablation. The repeat examination allows the extent of tissue destruction to be assessed, assure a clear and clean airway, and removal of devascularized cryoablative debris by forceps, aspiration, or cryoadhesion [<a href="#rid18">18,20,21,53,54</a>]. Additional bronchoscopic cryotherapy can be performed during the repeat examination, if necessary. (See <a class="local">'Cryoadhesion'</a> below.)</p><p class="headingAnchor" id="H4055164"><span class="h1">CRYOADHESION</span><span class="headingEndMark"> — </span>Cryoadhesion refers to the use of a cryoprobe to freeze freely mobile endoluminal material (eg, foreign body). Material is generally frozen to temperatures of -40ºC or below. Frozen target material adheres to the probe so that it can be removed.</p><p class="headingAnchor" id="H4061290"><span class="h2">Foreign body removal</span><span class="headingEndMark"> — </span>Cryoadhesion can be used to extract organic material including foreign bodies, mucous plugs, or blood clots (eg, due to cryoablation) [<a href="#rid55">55,56</a>]. The equipment and the procedure is similar to that described for cryoablation except the material is not subjected to thawing. (See <a class="local">'Equipment'</a> above and <a class="local">'Procedure and technique'</a> above.)</p><p>Small amounts of sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> can be utilized to saturate the foreign body (including nonorganic material) which further enhances freezing and consequent adhesion. The material is extracted by removing the cryoprobe through the open barrel of a rigid bronchoscope, or by removing both the cryoprobe and bronchoscope as one unit if a flexible bronchoscope is used.</p><p>Organic or biologic material is more readily frozen while inorganic matter is cryoresistant. Thus, the easiest types of objects to remove are friable items including blood clots and mucus plugs or biologic matter, such as pills, peanuts, teeth, peas, seeds, chicken bones, and chewing gum, and rarely other foreign bodies such as some types of hairpins, paper clips, and dental prostheses [<a href="#rid57">57</a>]. Though often thought that cryoadhesion cannot remove metal objects, such as most types of hairpins, nails, screws, and some tooth caps or plastic objects [<a href="#rid58">58</a>], applying sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or water can allow the probe to freeze to the foreign body. The approach to patients with airway foreign bodies as well as choosing among the types of extraction tools are discussed separately. (See <a class="local">'Equipment'</a> above and  <a class="medical medical_review" href="/d/html/4387.html" rel="external">"Airway foreign bodies in adults", section on 'Foreign body removal'</a>.)</p><p>Contraindications and complications are similar to those related to bronchoscopy. In addition, there is a slight risk of accidental airway perforation, although considerably lower than that associated with cryoablation. (See  <a class="medical medical_review" href="/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications", section on 'General considerations and precautions'</a> and  <a class="medical medical_review" href="/d/html/4400.html" rel="external">"Flexible bronchoscopy in adults: Indications and contraindications", section on 'Contraindications'</a> and <a class="local">'Complications'</a> above.)</p><p class="headingAnchor" id="H4055375"><span class="h1">CRYOBIOPSY</span><span class="headingEndMark"> — </span>Use of cryobiopsy is limited to centers with expertise.</p><p class="bulletIndent1"><span class="glyph">●</span>Technique – This technique involves subjecting tissue to cryofixation by a liquid cryogen to preserve tissue for subsequent morphologic and immunohistochemical analysis [<a href="#rid59">59-61</a>]. It theoretically avoids artifacts common to conventional preparation methods (eg, crush or fixation-induced artifacts) and yields biopsy samples three to four times larger than that achieved with a traditional biopsy forceps.</p><p></p><p class="bulletIndent1">Cryoforceps quickly freezes the target biopsy material at the temperature of liquid nitrogen (-196ºC). Similar to cryoablation, tissue type can affect the efficacy of this biopsy modality such that lung tissue is more amenable than cartilage to cryobiopsy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use and efficacy – Cryobiopsy is being increasingly used during bronchoscopic resections and during bronchoscopy to biopsy endobronchial lesions. Data describing the use of cryobiopsy for parenchymal and endobronchial lesions include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the largest retrospective study to date of 1024 patients who underwent cryobiopsy for parenchymal pulmonary lesions, the overall bleeding rate was 18 percent with 3.5 percent experiencing clinically significant bleeding [<a href="#rid62">62</a>]. Pneumothorax occurred in nearly 7 percent, the majority of whom required tube thoracostomy drainage. A definitive diagnosis was achieved in over 90 percent of patients.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one prospective series of 55 patients with endoluminal tumors, the diagnostic yield was higher with cryo-transbronchial biopsy (cryo-TBB) than with conventional TBB (89 versus 65 percent) and biopsies were larger [<a href="#rid63">63</a>]. Among patients who underwent cryo-TBB, bleeding was mild, moderate or severe in 4, 1, and 0.3 percent, respectively.</p><p></p><p class="bulletIndent1">Cryobiopsy is also being increasingly used in the diagnosis of diffuse interstitial lung disease (ILD). Data supporting its use and associated complications in the diagnosis of ILD are provided separately. (See  <a class="medical medical_review" href="/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease", section on 'Transbronchial cryobiopsy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Safety – Although original observational studies suggested that the rate of complications was low (less than 5 percent), subsequent studies report higher pneumothorax and bleeding rates than standard TBB.</p><p></p><p class="bulletIndent1">Newer technology may improve the safety. A new 1.1 mm cryoprobe that can be placed through a sheath is commercially available. This allows the bronchoscope to remain within the airway as the specimen is removed, potentially increasing the safety of the procedure. A small study investigating augmented-fluoroscopy-based navigation utilized this probe in 63 patients with peripheral pulmonary nodules (median nodule size 25 mm) [<a href="#rid64">64</a>]. In nine of the patients, a diagnosis was made solely by the cryoprobe, and there were no complications of major bleeding (defined as requiring intervention or admission).</p><p></p><p class="headingAnchor" id="H5429555"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Equipment</strong> – Several bronchoscopic cryosurgical techniques are available that employ extremely low temperatures to freeze tissue for destruction (cryoablation), adhesion (cryoadhesion), or biopsy (cryobiopsy). These procedures require a cryosurgery device, a bronchoscope, and a cooling agent (usually <a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">nitrous oxide</a>). (See <a class="local">'Introduction'</a> above and <a class="local">'Equipment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cryoablation</strong> – Bronchoscopic cryoablation (also known as cryotherapy) uses exceptionally low temperatures to destroy target tissue with repeated cycles of rapid freezing and slow thawing  (<a class="graphic graphic_figure graphicRef112826" href="/d/graphic/112826.html" rel="external">figure 1</a>). (See <a class="local">'Basic principles and mechanisms of action'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications</strong> – Bronchoscopic cryoablation is primarily a palliative or adjunctive therapy used to treat patients with symptomatic central airway obstruction (CAO) due to malignant and less commonly benign intraluminal lesions that are inoperable. It can also be used to treat hemoptysis due to an endobronchial lesion and inoperable microinvasive carcinoma. It is successful in achieving airway patency and/or palliating symptoms in up to 90 percent of cases. (See <a class="local">'Basic principles and mechanisms of action'</a> above and <a class="local">'Indications and efficacy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Contraindications</strong> – Bronchoscopic cryoablation should not be used in those with CAO from an extrinsic compression, those with life-threatening obstruction who need immediate relief or in those with general contraindications to bronchoscopy, general anesthesia, and/or procedural sedation. (See <a class="local">'Contraindications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedure</strong> – Bronchoscopic cryoablation can be administered via a flexible or rigid bronchoscope. A cryoprobe  (<a class="graphic graphic_picture graphicRef104187" href="/d/graphic/104187.html" rel="external">picture 1</a>) is placed directly in contact with the target tissue. Three freeze-thaw cycles are then carried out. The probe is then moved 5 to 6 mm and another three freeze-thaw cycles are performed. This is continued until the entire endobronchial lesion has been treated. (See <a class="local">'Procedure and technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complications</strong> – Adverse events occur in approximately 5 percent of cases or less, with delayed hemorrhage being the most common of the cryoablation-specific serious complications. Additional complications include airway perforation, airway edema, and mucus plugging, as well as complications related to bronchoscopy and/or sedation. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Follow-up</strong> – Bronchoscopic cryoablation does not require any particular immediate follow-up care in the absence of complications, other than routine post-bronchoscopy care. However, repeat bronchoscopy is generally performed 2 to 10 days after the initial procedure for the removal of cryoablative debris. (See <a class="local">'Follow-up'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cryoadhesion</strong> – Cryoadhesion uses a cryoprobe to freeze freely mobile endoluminal material to the probe so that it can be removed. The most common indication is the extraction of foreign bodies, mucous plugs, or blood clots. Organic material is more readily frozen whereas the extraction of inorganic objects (eg, metals, tooth caps) is less amenable to this modality. (See <a class="local">'Cryoadhesion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cryobiopsy</strong> – Cryobiopsy involves subjecting tissue to cryofixation by a liquid cryogen to preserve the tissue for subsequent morphologic and immunohistochemical analysis. Cryobiopsy is being increasingly used to obtain endobronchial and transbronchial lung tissue for solid lesions and for diffuse interstitial lung disease. (See <a class="local">'Cryobiopsy'</a> above and  <a class="medical medical_review" href="/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease", section on 'Transbronchial cryobiopsy'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bolliger CT, Mathur PN, Beamis JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 2002; 19:356.</a></li><li><a class="nounderline abstract_t">Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med 2004; 169:1278.</a></li><li><a class="nounderline abstract_t">Ernst A, Silvestri GA, Johnstone D, American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest 2003; 123:1693.</a></li><li class="breakAll">Homasson, JP, Bell, NJ. Cryotherapy in chest medicine, Springer Verlag, Paris 1992.</li><li><a class="nounderline abstract_t">Noppen M, Meysman M, Van Herreweghe R, et al. Bronchoscopic cryotherapy: preliminary experience. Acta Clin Belg 2001; 56:73.</a></li><li><a class="nounderline abstract_t">Gage AA, Guest K, Montes M, et al. Effect of varying freezing and thawing rates in experimental cryosurgery. Cryobiology 1985; 22:175.</a></li><li><a class="nounderline abstract_t">Smith JJ, Fraser J. An estimation of tissue damage and thermal history in the cryolesion. Cryobiology 1974; 11:139.</a></li><li><a class="nounderline abstract_t">Miller RH, Mazur P. Survival of frozen-thawed human red cells as a function of cooling and warming velocities. Cryobiology 1976; 13:404.</a></li><li><a class="nounderline abstract_t">Gage AA, Caruana JA Jr, Montes M. Critical temperature for skin necrosis in experimental cryosurgery. Cryobiology 1982; 19:273.</a></li><li><a class="nounderline abstract_t">Rand RW, Rand RP, Eggerding FA, et al. Cryolumpectomy for breast cancer: an experimental study. Cryobiology 1985; 22:307.</a></li><li><a class="nounderline abstract_t">Rubinsky, B, Ikeda, M. A cryomicroscope using directional solidification for the controlled freezing of biological tissue. Cryobiology 1985; 22:55.</a></li><li><a class="nounderline abstract_t">Gilbert JC, Onik GM, Hoddick WK, Rubinsky B. Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology 1985; 22:319.</a></li><li><a class="nounderline abstract_t">Benson JW. Combined chemotherapy and cryosurgery for oral cancer. Am J Surg 1975; 130:596.</a></li><li><a class="nounderline abstract_t">Vergnon JM, Huber RM, Moghissi K. Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J 2006; 28:200.</a></li><li><a class="nounderline abstract_t">Hetzel M, Hetzel J, Schumann C, et al. Cryorecanalization: a new approach for the immediate management of acute airway obstruction. J Thorac Cardiovasc Surg 2004; 127:1427.</a></li><li><a class="nounderline abstract_t">Prakash UB. Advances in bronchoscopic procedures. Chest 1999; 116:1403.</a></li><li><a class="nounderline abstract_t">Walsh DA, Maiwand MO, Nath AR, et al. Bronchoscopic cryotherapy for advanced bronchial carcinoma. Thorax 1990; 45:509.</a></li><li><a class="nounderline abstract_t">Maiwand MO, Homasson JP. Cryotherapy for tracheobronchial disorders. Clin Chest Med 1995; 16:427.</a></li><li><a class="nounderline abstract_t">Rodgers BM, Moazam F, Talbert JL. Endotracheal cryotherapy in the treatment of refractory airway strictures. Ann Thorac Surg 1983; 35:52.</a></li><li><a class="nounderline abstract_t">Mathur PN, Wolf KM, Busk MF, et al. Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction. Chest 1996; 110:718.</a></li><li><a class="nounderline abstract_t">Marasso A, Gallo E, Massaglia GM, et al. Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis. Indications, limits, personal experience. Chest 1993; 103:472.</a></li><li><a class="nounderline abstract_t">Asimakopoulos G, Beeson J, Evans J, Maiwand MO. Cryosurgery for malignant endobronchial tumors: analysis of outcome. Chest 2005; 127:2007.</a></li><li><a class="nounderline abstract_t">Schumann C, Hetzel M, Babiak AJ, et al. Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis. J Thorac Cardiovasc Surg 2010; 139:997.</a></li><li><a class="nounderline abstract_t">Ikekawa S, Ishihara K, Tanaka S, Ikeda S. Basic studies of cryochemotherapy in a murine tumor system. Cryobiology 1985; 22:477.</a></li><li><a class="nounderline abstract_t">Homasson JP, Pecking A, Roden S, et al. Tumor fixation of bleomycin labeled with 57 cobalt before and after cryotherapy of bronchial carcinoma. Cryobiology 1992; 29:543.</a></li><li><a class="nounderline abstract_t">Vergnon JM, Schmitt T, Alamartine E, et al. Initial combined cryotherapy and irradiation for unresectable non-small cell lung cancer. Preliminary results. Chest 1992; 102:1436.</a></li><li><a class="nounderline abstract_t">Forest V, Peoc'h M, Campos L, et al. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology 2005; 50:29.</a></li><li><a class="nounderline abstract_t">Forest V, Peoc'h M, Ardiet C, et al. In vivo cryochemotherapy of a human lung cancer model. Cryobiology 2005; 51:92.</a></li><li><a class="nounderline abstract_t">Forest V, Peoc'h M, Campos L, et al. Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model. Lung Cancer 2006; 54:79.</a></li><li><a class="nounderline abstract_t">Le Pivert PJ, Binder P, Ougier T. Measurement of intratissue bioelectrical low frequency impedance: a new method to predict per-operatively the destructive effect of cryosurgery. Cryobiology 1977; 14:245.</a></li><li><a class="nounderline abstract_t">Bertoletti L, Elleuch R, Kaczmarek D, et al. Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest 2006; 130:1405.</a></li><li><a class="nounderline abstract_t">Dalar L, Ozdemir C, Abul Y, et al. Endobronchial Treatment of Carcinoid Tumors of the Lung. Thorac Cardiovasc Surg 2016; 64:166.</a></li><li><a class="nounderline abstract_t">Eaton D, Beeson J, Maiwand O, Anikin V. Endoluminal cryotherapy in the management of endobronchial metastatic tumors of extrapulmonary origin. J Bronchology Interv Pulmonol 2015; 22:135.</a></li><li><a class="nounderline abstract_t">Nassiri AH, Dutau H, Breen D, et al. A multicenter retrospective study investigating the role of interventional bronchoscopic techniques in the management of endobronchial lipomas. Respiration 2008; 75:79.</a></li><li><a class="nounderline abstract_t">Maiwand MO, Zehr KJ, Dyke CM, et al. The role of cryotherapy for airway complications after lung and heart-lung transplantation. Eur J Cardiothorac Surg 1997; 12:549.</a></li><li><a class="nounderline abstract_t">Franke KJ, Nilius G, Rühle KH. [Cryorecanalization of an endobronchial lipoma]. Pneumologie 2005; 59:685.</a></li><li><a class="nounderline abstract_t">Taviot B, Coppere B, Pacheco Y, et al. [Tracheobronchial lipomatosis. Apropos of a case]. Rev Pneumol Clin 1987; 43:42.</a></li><li><a class="nounderline abstract_t">Sim JK, Choi JH, Oh JY, et al. Two Cases of Diagnosis and Removal of Endobronchial Hamartoma by Cryotherapy via Flexible Bronchoscopy. Tuberc Respir Dis (Seoul) 2014; 76:141.</a></li><li><a class="nounderline abstract_t">Ucar N, Akpinar S, Aktas Z, et al. Resection of endobronchial hamartoma causing recurrent hemoptysis by electrocautery and cryotherapy. Hippokratia 2014; 18:355.</a></li><li><a class="nounderline abstract_t">Lee H, Leem CS, Lee JH, et al. Successful removal of endobronchial blood clots using bronchoscopic cryotherapy at bedside in the intensive care unit. Tuberc Respir Dis (Seoul) 2014; 77:193.</a></li><li><a class="nounderline abstract_t">Rojas-Tula DG, Gómez-Fernández M, García-López JJ, et al. Endobronchial cryotherapy for a mycetoma. J Bronchology Interv Pulmonol 2013; 20:330.</a></li><li><a class="nounderline abstract_t">Mu D, Nan D, Li W, et al. Efficacy and safety of bronchoscopic cryotherapy for granular endobronchial tuberculosis. Respiration 2011; 82:268.</a></li><li><a class="nounderline abstract_t">Bhora FY, Ayub A, Forleiter CM, et al. Treatment of Benign Tracheal Stenosis Using Endoluminal Spray Cryotherapy. JAMA Otolaryngol Head Neck Surg 2016; 142:1082.</a></li><li><a class="nounderline abstract_t">Samad I, Akst L, Karatayli-Özgürsoy S, et al. Evaluation of Dyspnea Outcomes After Endoscopic Airway Surgery for Laryngotracheal Stenosis. JAMA Otolaryngol Head Neck Surg 2016; 142:1075.</a></li><li><a class="nounderline abstract_t">Vonk-Noordegraaf A, Postmus PE, Sutedja TG. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39:49.</a></li><li><a class="nounderline abstract_t">Schuurman B, Postmus PE, van Mourik JC, et al. Combined use of autofluorescence bronchoscopy and argon plasma coagulation enables less extensive resection of radiographically occult lung cancer. Respiration 2004; 71:410.</a></li><li><a class="nounderline abstract_t">Inoue M, Nakatsuka S, Jinzaki M. Cryoablation of early-stage primary lung cancer. Biomed Res Int 2014; 2014:521691.</a></li><li><a class="nounderline abstract_t">Krimsky WS, Broussard JN, Sarkar SA, Harley DP. Bronchoscopic spray cryotherapy: assessment of safety and depth of airway injury. J Thorac Cardiovasc Surg 2010; 139:781.</a></li><li><a class="nounderline abstract_t">Finley DJ, Dycoco J, Sarkar S, et al. Airway spray cryotherapy: initial outcomes from a multiinstitutional registry. Ann Thorac Surg 2012; 94:199.</a></li><li><a class="nounderline abstract_t">Browning R, Parrish S, Sarkar S, Turner JF Jr. First report of a novel liquid nitrogen adjustable flow spray cryotherapy (SCT) device in the bronchoscopic treatment of disease of the central tracheo-bronchial airways. J Thorac Dis 2013; 5:E103.</a></li><li><a class="nounderline abstract_t">Janke KJ, Abbas AE, Ambur V, Yu D. The Application of Liquid Nitrogen Spray Cryotherapy in Treatment of Bronchial Stenosis. Innovations (Phila) 2016; 11:349.</a></li><li><a class="nounderline abstract_t">Chudasama D, Rice A, Soppa G, Anikin V. Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy. Cryobiology 2015; 71:161.</a></li><li><a class="nounderline abstract_t">Homasson, JP. Bronchoscopic cryotherapy. J Bronchol 1995; 2:145.</a></li><li><a class="nounderline abstract_t">Homasson JP, Thiery JP, Angebault M, et al. The operation and efficacy of cryosurgical, nitrous oxide-driven cryoprobe. I. Cryoprobe physical characteristics: their effects on cell cryodestruction. Cryobiology 1994; 31:290.</a></li><li><a class="nounderline abstract_t">Rafanan AL, Mehta AC. Adult airway foreign body removal. What's new? Clin Chest Med 2001; 22:319.</a></li><li><a class="nounderline abstract_t">Weerdt S, Noppen M, Remels L, et al. Successful removal of a massive endobronchial clot by means of cryotherapy. Journal of Bronchology 2005; 12:23.</a></li><li><a class="nounderline abstract_t">Jabbardarjani R, Kiani A, Arab A. Nat Res Inst Tuberc and Lung Dis 2009; 8:60.</a></li><li><a class="nounderline abstract_t">Hewlett JC, Rickman OB, Lentz RJ, et al. Foreign body aspiration in adult airways: therapeutic approach. J Thorac Dis 2017; 9:3398.</a></li><li><a class="nounderline abstract_t">Babiak A, Hetzel J, Krishna G, et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 2009; 78:203.</a></li><li><a class="nounderline abstract_t">Hetzel J, Hetzel M, Hasel C, et al. Old meets modern: the use of traditional cryoprobes in the age of molecular biology. Respiration 2008; 76:193.</a></li><li><a class="nounderline abstract_t">Franke KJ, Szyrach M, Nilius G, et al. Experimental study on biopsy sampling using new flexible cryoprobes: influence of activation time, probe size, tissue consistency, and contact pressure of the probe on the size of the biopsy specimen. Lung 2009; 187:253.</a></li><li><a class="nounderline abstract_t">Herth FJ, Mayer M, Thiboutot J, et al. Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions. Chest 2021; 160:1512.</a></li><li><a class="nounderline abstract_t">Schumann C, Hetzel J, Babiak AJ, et al. Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg 2010; 140:417.</a></li><li><a class="nounderline abstract_t">Pertzov B, Gershman E, Izhakian S, et al. The LungVision navigational platform for peripheral lung nodule biopsy and the added value of cryobiopsy. Thorac Cancer 2021; 12:2007.</a></li></ol></div><div id="topicVersionRevision">Topic 4407 Version 38.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11866017" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15187010" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Central airway obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12740291" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12740291" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11383315" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bronchoscopic cryotherapy: preliminary experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3979086" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Effect of varying freezing and thawing rates in experimental cryosurgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4452257" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : An estimation of tissue damage and thermal history in the cryolesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/971585" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Survival of frozen-thawed human red cells as a function of cooling and warming velocities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7105779" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Critical temperature for skin necrosis in experimental cryosurgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2992882" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cryolumpectomy for breast cancer: an experimental study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A cryomicroscope using directional solidification for the controlled freezing of biological tissue</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3896654" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Real time ultrasonic monitoring of hepatic cryosurgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1081843" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Combined chemotherapy and cryosurgery for oral cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16816349" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15116003" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cryorecanalization: a new approach for the immediate management of acute airway obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10559105" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Advances in bronchoscopic procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1697705" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Bronchoscopic cryotherapy for advanced bronchial carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8521698" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cryotherapy for tracheobronchial disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6849581" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Endotracheal cryotherapy in the treatment of refractory airway strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8797417" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8432138" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis. Indications, limits, personal experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15947313" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cryosurgery for malignant endobronchial tumors: analysis of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19716140" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2414064" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Basic studies of cryochemotherapy in a murine tumor system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1385037" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Tumor fixation of bleomycin labeled with 57 cobalt before and after cryotherapy of bronchial carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1330447" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Initial combined cryotherapy and irradiation for unresectable non-small cell lung cancer. Preliminary results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15710367" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15963488" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : In vivo cryochemotherapy of a human lung cancer model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16889870" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/862420" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Measurement of intratissue bioelectrical low frequency impedance: a new method to predict per-operatively the destructive effect of cryosurgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17099017" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984778" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Endobronchial Treatment of Carcinoid Tumors of the Lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25887009" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Endoluminal cryotherapy in the management of endobronchial metastatic tumors of extrapulmonary origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17923776" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A multicenter retrospective study investigating the role of interventional bronchoscopic techniques in the management of endobronchial lipomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9370397" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The role of cryotherapy for airway complications after lung and heart-lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16222580" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : [Cryorecanalization of an endobronchial lipoma].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3589340" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : [Tracheobronchial lipomatosis. Apropos of a case].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24734103" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Two Cases of Diagnosis and Removal of Endobronchial Hamartoma by Cryotherapy via Flexible Bronchoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26052204" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Resection of endobronchial hamartoma causing recurrent hemoptysis by electrocautery and cryotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25368667" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Successful removal of endobronchial blood clots using bronchoscopic cryotherapy at bedside in the intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24162117" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Endobronchial cryotherapy for a mycetoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21150172" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Efficacy and safety of bronchoscopic cryotherapy for granular endobronchial tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27532803" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Treatment of Benign Tracheal Stenosis Using Endoluminal Spray Cryotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27533026" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Evaluation of Dyspnea Outcomes After Endoscopic Airway Surgery for Laryngotracheal Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12499094" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316217" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Combined use of autofluorescence bronchoscopy and argon plasma coagulation enables less extensive resection of radiographically occult lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24991559" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cryoablation of early-stage primary lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19664781" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Bronchoscopic spray cryotherapy: assessment of safety and depth of airway injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22516831" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Airway spray cryotherapy: initial outcomes from a multiinstitutional registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23825781" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : First report of a novel liquid nitrogen adjustable flow spray cryotherapy (SCT) device in the bronchoscopic treatment of disease of the central tracheo-bronchial airways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27662476" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The Application of Liquid Nitrogen Spray Cryotherapy in Treatment of Bronchial Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26043899" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Bronchoscopic cryotherapy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8050273" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The operation and efficacy of cryosurgical, nitrous oxide-driven cryoprobe. I. Cryoprobe physical characteristics: their effects on cell cryodestruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11444115" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Adult airway foreign body removal. What's new?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Successful removal of a massive endobronchial clot by means of cryotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : </p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29221325" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Foreign body aspiration in adult airways: therapeutic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19246874" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Transbronchial cryobiopsy: a new tool for lung biopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18708736" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Old meets modern: the use of traditional cryoprobes in the age of molecular biology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19548030" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Experimental study on biopsy sampling using new flexible cryoprobes: influence of activation time, probe size, tissue consistency, and contact pressure of the probe on the size of the biopsy specimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33971147" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20226474" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34096182" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The LungVision navigational platform for peripheral lung nodule biopsy and the added value of cryobiopsy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
